BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/6/2020 9:52:06 AM | Browse: 986 | Download: 2459
 |
Received |
|
2020-03-18 13:20 |
|
Peer-Review Started |
|
2020-03-18 13:22 |
|
First Decision by Editorial Office Director |
|
2020-04-22 18:48 |
|
Return for Revision |
|
2020-04-22 18:48 |
|
Revised |
|
2020-06-07 12:07 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2020-07-15 12:03 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2020-07-16 01:44 |
|
Articles in Press |
|
2020-07-16 01:44 |
|
Edit the Manuscript by Language Editor |
|
2020-07-20 00:44 |
|
Typeset the Manuscript |
|
2020-08-04 06:12 |
|
Publish the Manuscript Online |
|
2020-08-06 09:52 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Case Report |
| Article Title |
Facial and bilateral lower extremity edema due to drug-drug interactions in a patient with hepatitis C virus infection and benign prostate hypertrophy: A case report
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Ya-Ping Li, Ying Yang, Mu-Qi Wang, Xin Zhang, Wen-Jun Wang, Mei Li, Feng-Ping Wu and Shuang-Suo Dang |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Natural Science Foundation of China |
81701632 |
| Shanxi Province Social Development Project |
2018SF-269 |
|
| Corresponding Author |
Shuang-Suo Dang, PhD, Professor, Department of Infectious Diseases, Second Affiliated Hospital of Xi'an Jiaotong University, No.157, Xiwu Road, Xincheng District, Xi'an 710004, Shanxi Province, China. dangshuangsuo123@xjtu.edu.cn |
| Key Words |
Direct-acting antivirals; Hepatitis C virus; Sofosbuvir/velpatasvir; Drug-drug interactionss; Case report; |
| Core Tip |
In this manuscript, we reported a case of drug-drug interaction in a 46 years old man, who was diagnosed as hepatitis C virus infection with benign prostatic hypertrophy. The patient received sofosbuvir/velpatasvir as well as methadone maintenance therapy for drug abuse. The viral load became negative at week 1 post treatment. He developed facial and bilateral lower extremity edema 48 h after starting receiving tamsulosin. Edema disappeared 10 d after treatment with oral furosemide and spironolactone. This case could be useful in clinical management of patients with hepatitis C virus infection and attention of drug-drug interactions in this subset of patients. |
| Publish Date |
2020-08-06 09:52 |
| Citation |
Li YP, Yang Y, Wang MQ, Zhang X, Wang WJ, Li M, Wu FP, Dang SS. Facial and bilateral lower extremity edema due to drug-drug interactions in a patient with hepatitis C virus infection and benign prostate hypertrophy: A case report. World J Clin Cases 2020; 8(15): 3372-3376 |
| URL |
https://www.wjgnet.com/2307-8960/full/v8/i15/3372.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v8.i15.3372 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
